某院心内科住院患者质子泵抑制剂合理用药分析  

Rationality Use of Proton Pump Inhibitors in Hospitalized Patients in the Department of Cardiology in a Hospital

作　　者：丁全[1] 刘宪军[1] 成华[1] 张晓兰[1] DING Quan;LIU Xianjun;CHENG Hua;ZHANG Xiaolan(Department of Pharmacy,Beijing Lahe Hospital,Captial Medical University,Bejing,China 101149)

机构地区：[1]首都医科大学附属北京潞河医院药学部,北京101149

出　　处：《中国药业》2021年第21期20-22,共3页China Pharmaceuticals

基　　金：北京市科技计划项目[Z181100001718144]。

摘　　要：目的提高质子泵抑制剂(PPI)使用的合理性。方法随机抽取医院信息系统中2019年1月至12月心内科和冠状动脉粥样硬化性心脏病重症监护室(CCU)使用PPI的病历200份,统计患者的基本信息、用药情况及不合理用药情况,并分析不合理用药的原因。结果 200例患者中,不合理用药132例(66.00%)。其中,无用药指征11例(8.33%);用药途径不适宜89例(67.42%),即可口服给药但选用静脉给药;剂量不适宜29例(21.97%);重复用药3例(2.27%)。结论该院心内科和CCU住院患者存在不合理使用PPI的情况,需制订和实施相关干预措施,规范PPI的临床使用。Objective To improve the rationality use of proton pump inhibitors(PPI).Methods A total of 200 medical records of PPI use in the Department of Cardiology and coronary heart disease care unit(CCU)from January to December 2019 in the hospital information system(HIS)were randomly selected,the basic information,drug use and irrational drug use of patients were counted,and the causes of irrational drug use were analyzed.Results Among the 200 patients,132 patients(66.00%)had irrational drug use.Among them,there were 11 patients(8.33%)with medication without indication,89 patients(67.42%)with the inappropriate route of medication,which could be administered orally but intravenously,29 patients(21.91%)with inappropriate dose,and three patients(2.27%)with repeated medication.Conclusion The use of PPI for inpatients in the Department of Cardiology and CCU in our hospital is unreasonable.It is necessary to formulate and implement relevant intervention measures to standardize the clinical use of PPI.

关 键 词：质子泵抑制剂 临床药师 合理用药 

分 类 号：R969.3[医药卫生—药理学]